Escalier Biosciences   Report issue

For profit Phase 2
Founded: Nijmegen Netherlands (2016)

Organization Overview

First Clinical Trial
2018
NCT03630939
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Escalier Biosciences B.V.